ACTRN12622001217796: A Randomised Controlled Trial of the efficacy and safety of an Inhaled Corticosteroid and Long Acting Beta Agonist maintenance and/or reliever therapy versus standard maintenance with separate reliever therapy in children with mild, moderate and severe asthma. |
|
|
| Recruiting | 3 | 400 | | | Medical Research Institute of New Zealand, AstraZeneca Ltd | Asthma | | | | |
| Completed | 3 | 450 | | one inhalation of Pulmicort Turbuhaler 200 ug/inhalation ;Oxis Turbuhaler 4.5 ug/inhalation with symptom-driving ;Symbicort Turbuhaler 160/4.5 ug/inhalation with symptom-driving | 1st Affiliated Hospital of SYSU; 2nd and 3rd Affiliated Hospital of SYSU, 1st Affiliated Hospital of SYSU | mild asthma | | | | |
2005-005469-12: A Phase III, randomised, double-blind, double-dummy cross-over study to compare two dry powder inhaled formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, moderate asthma. |
|
|
| Ongoing | 3 | 30 | Europe | Budesonide Test DPI, Pulmicort Turbohaler 200, Test DPI, Reference DPI, Pulmicort Turbohaler 200, Pulmicort Turbohaler 200 | Neolab Limited | Stable, persistent, moderate asthma | | | | |
ChiCTR-TRC-12002459: Therapeutic effect of inhaled budesonide (Pulmicort Turbuhaler) on lung inflammatory response to the one lung ventilation |
|
|
| Completed | N/A | 60 | | nebulized saline ;nebulized budesonide | Department of ICU, The Affiliated Tumor Hospital, Harbin Medical University; Level of the institution:, NO | lung cancer | | | | |